Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Patient-Reported Disease Activity, Health-Related Quality of Life, and Coping in Systemic Lupus Erythematosus: A Cross-Sectional Online Survey in Switzerland (Lupus-IMPACT).

Created on 26 Oct 2026

Authors

Marten Trendelenburg, Jasmin Annabelle Schulz, Kristin Schmiedeberg, Johannes von Kempis, Alessandra Girardi, Marie-Louise Hagen-Perrenoud, Chiara Balbo Pogliano, Philipp M Wörner, Peter Langer, Shekoofeh Yaghmaei, Carlo Chizzolini

Published in

Rheumatology and therapy. Oct 25, 2026. Epub Oct 25, 2026.

Abstract

The impact of systemic lupus erythematosus (SLE) on the quality of life is differently perceived by patients and physicians. This survey explored the patient perception of SLE burden, challenges, and strategies of coping.
Adults with a self-reported physician-diagnosis of SLE, living in Switzerland, were recruited to participate in a cross-sectional online survey through a patient association, a physician-confirmed national SLE registry, and a digital campaign. Health-related quality of life (HRQoL) was assessed using the Lupus Patient-Reported Outcome scale (LupusPRO®), disease activity using the Systemic Lupus Activity Questionnaire (SLAQ), and coping using the Brief Coping Orientation to Problems Experienced (COPE) inventory, in addition to a patient satisfaction questionnaire.
Between February and June 2024, 146 participants completed the survey. Participants had a median age of 48.5 years (IQR 25), and 85.6% were female. Nearly all participants (92.5%) were receiving pharmacological treatments, with a median of six medications taken daily. In the preceding three months, patients reported mild (36.3%), moderate (21.9%), and severe (6.8%) flares. Participants reported impaired HRQoL, with especially affected domains of emotional health, cognition, pain and fatigue. Predominant coping domains were problem-focused in 106 participants (72.6%), emotion-focused in 25 (17.1%), avoidant-focused in 11 (7.5%), tied problem-/emotion-focused in 2 (1.4%), and tied problem-/avoidant-focused in 2 (1.4%). Fatigue reduction was the treatment goal most often reported by participants.
In this cross-sectional Swiss survey, patients with SLE reported impaired HRQoL, frequent recent flares, and fatigue reduction as the most common treatment priority despite ongoing therapy. Problem-focused coping was the predominant coping style. These findings underscore the value of patient-reported outcomes in complementing clinical assessment and capturing patient-important disease burden. However, potential selection, non-response, confounding, and diagnostic uncertainties limit generalisability, and the cross-sectional design precludes conclusions about causality or intervention benefit.

PMID:
42928404
Bibliographic data and abstract were imported from PubMed on 26 Oct 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 10
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement